At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions.
Novo Nordisk Canada Inc. is an affiliate of Novo Nordisk A/S, a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: hemophilia, growth disorders and obesity.
Headquartered in Denmark, Novo Nordisk employs approximately 41,600 people in 80 countries and markets its products in 170 countries.
member
Seven Oaks Capital Corp.is pleased to announce that it has entered into a binding letter agreement dated January 29, 2023 (the "Definitive Agreement") with Rimon Hedge Funds Ltd.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.